Review regulatory requirements and the use of viral-challenge studies in drug development.
Bruno Speder
Advertisement
Bruno Speder is head of clinical regulatory affairs, Clinical Research, SGS Life Science Services, Bruno.Speder@sgs.com.
Articles by Bruno Speder
Advertisement
Latest Updated Articles
Regulatory Requirements for Viral-Challenge Studies: Influenza Case StudyPublished: May 1st 2014 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
